Cargando…
Bronchiectasis - Exercise as Therapy (BREATH): rationale and study protocol for a multi-center randomized controlled trial
BACKGROUND: Globally, bronchiectasis (BE) unrelated to cystic fibrosis (CF) is recognized as a major cause of respiratory morbidity, mortality, and healthcare utilization. Children with BE regularly experience exacerbations of their condition resulting in frequent hospitalizations and decreased heal...
Autores principales: | Jones, Taryn, O’Grady, Kerry-Ann F., Goyal, Vikas, Masters, Ian B., McCallum, Gabrielle, Drovandi, Christopher, Lung, Thomas, Baque, Emmah, Brookes, Denise S. K., Terranova, Caroline O., Chang, Anne B., Trost, Stewart G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996596/ https://www.ncbi.nlm.nih.gov/pubmed/35410363 http://dx.doi.org/10.1186/s13063-022-06256-2 |
Ejemplares similares
-
Barriers and facilitators of physical activity in children with bronchiectasis: Perspectives from children and parents
por: Jones, Taryn, et al.
Publicado: (2022) -
Antibiotics for bronchiectasis exacerbations in children: rationale and study protocol for a randomised placebo-controlled trial
por: Chang, Anne B, et al.
Publicado: (2012) -
Amoxicillin–clavulanate versus azithromycin for respiratory exacerbations in children with bronchiectasis (BEST-2): a multicentre, double-blind, non-inferiority, randomised controlled trial
por: Goyal, Vikas, et al.
Publicado: (2018) -
Efficacy of oral amoxicillin–clavulanate or azithromycin for non-severe respiratory exacerbations in children with bronchiectasis (BEST-1): a multicentre, three-arm, double-blind, randomised placebo-controlled trial
por: Goyal, Vikas, et al.
Publicado: (2019) -
Health-resource use and quality of life in children with bronchiectasis: a multi-center pilot cohort study
por: Lovie-Toon, Yolanda G., et al.
Publicado: (2019)